Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

Download All
Review the latest evidence-based strategies for HR-positive/HER2-negative early breast cancer with an on-demand webcast, downloadable slides from a live presentation series, a series of expert commentaries, a downloadable patient resource, and a patient’s story podcast.
Erika P. Hamilton, MD
Program Director
Joyce O'Shaughnessy, MD
Program Director
Julia LaBarbera, MSN, RN, AGACNP-BC
person default
Zoe Lanham
Joyce O'Shaughnessy, MD

Downloadable Patient Resource

Download this resource for your patients with HR-positive/HER2-negative early breast cancer to help aid planning of their care.

Julia LaBarbera, MSN, RN, AGACNP-BC Released: November 16, 2022

Downloadable Slideset

Download this slideset from a live meeting series to learn about multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer.

Erika P. Hamilton, MD
Program Director
Joyce O'Shaughnessy, MD
Program Director
Released: November 16, 2022

ClinicalThought

An expert discusses the impact of risk of recurrence on treatment selection for patients with early‑stage hormone receptor–positive/HER2‑negative breast cancer.

Joyce O'Shaughnessy, MD Released: November 14, 2022

Patient Video

Watch this brief video in which a patient describes the importance of communication between patients and their healthcare providers.

person default Zoe Lanham Released: November 16, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings